Halozyme Therapeutics HALO
NASDAQ HALO
$106.94 -3.46 (-3.13%)
At close: Oct 1, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Retained Earnings (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) posted Retained Earnings of $151.26 million for Q2 2026, down 58.1% from $361.03 million a year earlier and down 26.2% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Retained Earnings (2010 - 2026) Analysis & Trends

At the end of FY2025, Halozyme Therapeutics' Retained Earnings came in at $54.79 million, down 84.8% from FY2024.

  • In prior years, Halozyme Therapeutics' Retained Earnings was $359.87 million in FY2024 (+297.4%), $90.55 million in FY2023 (-36.8%), $143.22 million in FY2022 and -$58.91 million in FY2021.
  • Quarterly Retained Earnings has run from a low of -$125.68 million in Q3 2021 to a high of $502.15 million in Q3 2025 over five years.
  • On a year-over-year basis, Retained Earnings has declined in each of the last three quarters, with growth averaging 53.3% over the last eight quarters.
  • The strongest year-over-year quarter for Retained Earnings in the past five years was Q2 2023, with growth of 488.1%; the weakest was Q4 2025, with a decline of 84.8%.
  • According to Business Quant data, Retained Earnings for the three prior quarters was $204.84 million (Q1 2026), $54.79 million (Q4 2025) and $502.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 171.67 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -17.33 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 12.59 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 15.69 Bn
10 Halozyme Therapeutics 12.59 Bn 11.20 Bn 401.83 Mn 151.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 151.26 Mn
Mar 31, 2026 204.84 Mn
Dec 31, 2025 54.79 Mn
Sep 30, 2025 502.15 Mn
Jun 30, 2025 361.03 Mn
Mar 31, 2025 477.96 Mn
Dec 31, 2024 359.87 Mn
Sep 30, 2024 397.63 Mn
Jun 30, 2024 260.62 Mn
Mar 31, 2024 167.37 Mn
Dec 31, 2023 90.55 Mn
Sep 30, 2023 222.29 Mn
Jun 30, 2023 140.45 Mn
Mar 31, 2023 65.69 Mn
Dec 31, 2022 143.22 Mn
Sep 30, 2022 85.52 Mn
Jun 30, 2022 23.88 Mn
Mar 31, 2022 1.20 Mn
Dec 31, 2021 -58.91 Mn
Sep 30, 2021 -125.68 Mn
API Access

Halozyme Therapeutics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=HALO&period=max&api_key=YOUR_API_KEY